Cigna Q3 2026: revenue up 6.0%, adjusted EPS $7.98 beats, outlook raised
Cigna's third quarter beat on the adjusted number and management lifted the full-year outlook, so the quarter reads Bullish even though reported profit fell. Revenue rose 6.0% to $73.68 billion and adjusted EPS of $7.98 topped the $7.7255 consensus. Read the GAAP decline as a comparison artifact, since last year's quarter carried a gain on sale, then check the pharmacy benefit profit line, which fell 22.0%.
1 · Expected vs. Actual
Free preview belowAdjusted EPS of $7.98 beat the $7.7255 consensus by roughly $0.25, or about 3.3%. GAAP EPS fell to $5.47 from $6.98, but most of that gap is last year's after-tax gain on sale plus $449 million of acquired-intangible amortization this year. Adjusted income from operations was flat at $2.10 billion, so the beat came from the per-share line, not from higher profit.
Revenue came in at $73.68 billion, up 6.0% from $69.75 billion a year earlier. Pharmacy Benefit Services supplied $37.28 billion of that on 9.0% growth driven by drug mix, while Cigna Healthcare added $11.71 billion on premium rate increases. Gross margin held at 20.5%, essentially unchanged from 20.4%.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-05
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.